Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Articles
BioCentury
|
Jun 27, 2020
Product Development
Modeling harmony: learning from preclinical coordination of COVID-19 countermeasures
...clinic. Most of the attention has gone to clinical trials, where master protocols represent the
vanguard
...
Read More
BioCentury
|
Jul 26, 2016
Politics & Policy
FDA unveils draft guidance on real-world evidence for devices
...on the guidance. FDA's Center for Devices and Radiological Health also has been in the
vanguard
...
Read More
BioCentury
|
Jun 29, 2015
Product Development
Would you rather?
...device labeling." (2015) Sidebars FDA's Center for Devices and Radiological Health has been in the
vanguard
...
Read More
BioCentury
|
May 26, 2014
Company News
Human Longevity management update
...Bradley Perkins as CMO, formerly EVP for strategy and innovation and chief transformation officer of
Vanguard
...
Read More
BioCentury
|
Jan 21, 2013
Company News
MonoSol Rx, Vestiq deal
...to serve as the company's wholly owned branded pharmaceuticals subsidiary. Additionally, the company partnered with
Vanguard
...
Read More
BioCentury
|
Feb 27, 2012
Finance
Cashing in on Qnexa
...9.7%); QVT Financial (9.6%); Suttonbrook Capital Management (5.7%); First Manhattan (4.6%); Passport Capital (4.8%); and
Vanguard
...
Read More
BioCentury
|
Aug 8, 2011
Finance
Dendreon's scalded investors
...7.5 million shares at the end of March. Other investors at March 31 included the
Vanguard
...
Read More
BioCentury
|
Aug 16, 2010
Finance
Mann takes Seaside trip
...April 30. The next two largest shareholders are
Vanguard
Group and LMM. At June 30,
Vanguard
...
Read More
BioCentury
|
Jun 28, 2010
Finance
Frazier's Juggling Act
...7.2 million; 14.3%); Wellington Management (3.6 million; 7.2%); T. Rowe Price (2.9 million; 5.7%); and
Vanguard
...
Read More
BioCentury
|
Dec 7, 2009
Strategy
Two Genomic Sagas
...Despite being in the
vanguard
of the genomics revolution, deCode Genetics Inc. struggled to take up...
Read More
Items per page:
10
1 - 10 of 149
BioCentury
|
Jun 27, 2020
Product Development
Modeling harmony: learning from preclinical coordination of COVID-19 countermeasures
...clinic. Most of the attention has gone to clinical trials, where master protocols represent the
vanguard
...
Read More
BioCentury
|
Jul 26, 2016
Politics & Policy
FDA unveils draft guidance on real-world evidence for devices
...on the guidance. FDA's Center for Devices and Radiological Health also has been in the
vanguard
...
Read More
BioCentury
|
Jun 29, 2015
Product Development
Would you rather?
...device labeling." (2015) Sidebars FDA's Center for Devices and Radiological Health has been in the
vanguard
...
Read More
BioCentury
|
May 26, 2014
Company News
Human Longevity management update
...Bradley Perkins as CMO, formerly EVP for strategy and innovation and chief transformation officer of
Vanguard
...
Read More
BioCentury
|
Jan 21, 2013
Company News
MonoSol Rx, Vestiq deal
...to serve as the company's wholly owned branded pharmaceuticals subsidiary. Additionally, the company partnered with
Vanguard
...
Read More
BioCentury
|
Feb 27, 2012
Finance
Cashing in on Qnexa
...9.7%); QVT Financial (9.6%); Suttonbrook Capital Management (5.7%); First Manhattan (4.6%); Passport Capital (4.8%); and
Vanguard
...
Read More
BioCentury
|
Aug 8, 2011
Finance
Dendreon's scalded investors
...7.5 million shares at the end of March. Other investors at March 31 included the
Vanguard
...
Read More
BioCentury
|
Aug 16, 2010
Finance
Mann takes Seaside trip
...April 30. The next two largest shareholders are
Vanguard
Group and LMM. At June 30,
Vanguard
...
Read More
BioCentury
|
Jun 28, 2010
Finance
Frazier's Juggling Act
...7.2 million; 14.3%); Wellington Management (3.6 million; 7.2%); T. Rowe Price (2.9 million; 5.7%); and
Vanguard
...
Read More
BioCentury
|
Dec 7, 2009
Strategy
Two Genomic Sagas
...Despite being in the
vanguard
of the genomics revolution, deCode Genetics Inc. struggled to take up...
Read More
Items per page:
10
1 - 10 of 149
Previous page
Next page